Repronex (Menotropins) - Drug Interactions, Contraindications, Overdosage, etc

DRUG INTERACTIONS

No drug/drug interaction studies have been conducted for Repronex® in humans.

OVERDOSAGE

Aside from possible ovarian hyperstimulation (see WARNINGS), little is known concerning the consequences of acute overdosage with menotropins.

CONTRAINDICATIONS

Repronex® is contraindicated in women who have:

1. A high FSH level indicating primary ovarian failure.
2. Uncontrolled thyroid and adrenal dysfunction.
3. An organic intracranial lesion such as a pituitary tumor.
4. The presence of any cause of infertility other than anovulation unless they are candidates for in vitro -fertilization.
5. Abnormal bleeding of undetermined origin.
6. Ovarian cysts or enlargement not due to polycystic ovary syndrome.
7. Prior hypersensitivity to menotropins.
8. Repronex® is not indicated in women who are pregnant. There are limited human data on the effects of menotropins when administered during pregnancy.